[Form 4] Iridex Corp Insider Trading Activity

Rhea-AI Filing Summary

Romeo R. Dizon, Chief Financial Officer of IRIDEX Corp (IRIX), reported four separate purchases of common stock on 08/25/2025. Each transaction (code P) was for 250 shares at prices of $1.25, $1.245, $1.24 and $1.2454, increasing his reported beneficial ownership sequentially to 47,995, 48,245, 48,495 and 48,745 shares. The Form 4 was signed by an attorney-in-fact on 08/26/2025.

Insights

Financial Analyst

TL;DR: Routine insider purchases by the CFO totaling 1,000 shares at low single-digit dollar prices; appears immaterial to valuation.

The filing documents four small open-market purchases on a single day by the issuer's CFO, each of 250 shares at prices between $1.24 and $1.25, bringing reported beneficial ownership to 48,745 shares. The transactions are coded P (purchase) and were reported on Form 4 with an attorney-in-fact signature the next day. Given the absolute size and price levels disclosed, these trades are modest in dollar value and constitute routine disclosure of insider activity rather than a material corporate event.

Corporate Governance Expert

TL;DR: Proper Form 4 disclosure of insider purchases; documentation and signature appear in order.

The report identifies the reporting person as the Chief Financial Officer and indicates individual filing status. Transactions are clearly marked with dates, codes and per-share prices. The signature block shows an attorney-in-fact executed the form on 08/26/2025. From a governance and disclosure perspective, the filing meets Section 16(a) reporting requirements by documenting the changes in beneficial ownership promptly and with required detail.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Dizon Romeo R

(Last) (First) (Middle)

1212 TERRA BELLA AVENUE

(Street)

MOUNTAIN VIEW CA 94043

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
IRIDEX CORP [ IRIX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Financial Officer

3. Date of Earliest Transaction (Month/Day/Year)
08/25/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	08/25/2025		P		250	A	$1.25	47,995	D
Common Stock	08/25/2025		P		250	A	$1.245	48,245	D
Common Stock	08/25/2025		P		250	A	$1.24	48,495	D
Common Stock	08/25/2025		P		250	A	$1.2454	48,745	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

	/s/ Nilo De Castro, Attorney-in-fact for Romeo R. Dizon	08/26/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What transactions did IRIX insider Romeo R. Dizon report on Form 4?

The CFO reported four purchases of 250 shares each on 08/25/2025 (transaction code P).

At what prices were the IRIX shares purchased by the reporting person?

The reported purchase prices were $1.25, $1.245, $1.24 and $1.2454 per share.

How many IRIX shares did Romeo R. Dizon own after these transactions?

Beneficial ownership reported sequentially as 47,995, 48,245, 48,495 and 48,745 shares following each purchase.

When was the Form 4 signed and by whom?

The form shows a signature by Nilo De Castro, Attorney-in-fact for Romeo R. Dizon dated 08/26/2025.

What is the reporting person’s role at IRIDEX Corp?

The filing identifies the reporting person as an Officer with the title Chief Financial Officer.